Eric Wei insider trades: Caladrius Biosciences (CLBS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eric reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 7, 2017 | CLBS | ↓ Sell10b5-1 | 6,575 | $4.77 | $31K | Indirect | Feb 8, 2017 (1d) |
| Feb 6, 2017 | CLBS | ↓ Sell10b5-1 | 8,425 | $4.61 | $39K | Indirect | Feb 6, 2017 (0d) |
| Nov 21, 2016 | CLBS | ↓ Sell | 500 | $4.20 | $2K | Indirect | Nov 25, 2016 (4d) |
| Jul 1, 2016 | CLBS | ↓ Sell10b5-1 | 87,500 | $0.60 | $53K | Indirect | Jul 5, 2016 (4d) |
| Jun 24, 2016 | CLBS | ↓ Sell10b5-1 | 22,698 | $0.55 | $12K | Indirect | Jun 27, 2016 (3d) |
| Mar 6, 2016 | CLBS | ↓ Sell | 77,302 | $0.55 | $43K | Indirect | Jun 6, 2016 (92d) |
| Mar 18, 2015 | NBS | ↓ Sell | 100,000 | $3.20 | $320K | Indirect | Mar 20, 2015 (2d) |
| Dec 9, 2014 | NBS | ↓ Sell | 13,940 | $3.53 | $49K | Direct | Jan 2, 2015 (24d) |
| Dec 8, 2014 | NBS | ↓ Sell | 16,060 | $3.75 | $60K | Direct | Dec 9, 2014 (1d) |
| Dec 3, 2014 | NBS | ↓ Sell | 12,000 | $4.01 | $48K | Direct | Dec 4, 2014 (1d) |
| Dec 9, 2013 | NBS | ↓ Sell | 12,530 | $6.37 | $80K | Indirect | Dec 10, 2013 (1d) |
| Dec 9, 2013 | NBS | ↓ Sell | 12,530 | $6.37 | $80K | Direct | Dec 10, 2013 (1d) |
| Nov 26, 2013 | NBS | ↓ Sell | 10,000 | $6.26 | $63K | Indirect | Nov 29, 2013 (3d) |
| Nov 26, 2013 | NBS | ↓ Sell | 10,000 | $6.26 | $63K | Direct | Nov 29, 2013 (3d) |
| Feb 18, 2010 | NBS | ↑ Buy | 740,741 | $1.35 | $1.0M | Indirect | Feb 22, 2010 (4d) |
| Feb 18, 2010 | NBS | ↑ Buy | 740,741 | $1.35 | $1.0M | Direct | Feb 22, 2010 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Eric Wei's insider trades
Eric Wei is a director at Caladrius Biosciences (CLBS). Since Feb 18, 2010, Eric has reported 2 open-market purchases worth $2.0M and 14 sales worth $943K on SEC Form 4. There have been no open-market trades in the last 12 months.
4 sales (14% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include gifts (12 filings), grants and awards (10 filings), other transactions (4 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLBS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.